303 related articles for article (PubMed ID: 19581182)
1. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
2. [Serum levels of sex steroid and pituitary hormones in chronic alcoholics and head and neck cancer patients as compared to normal controls].
Remenár E; Számel I; Budai B; Gaudi I; Kásler M; Gundy S
Magy Onkol; 2002; 46(4):329-32. PubMed ID: 12563355
[TBL] [Abstract][Full Text] [Related]
3. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma].
Remenár E; Számel I; Budai B; Orosz Z; Gaudi I; Kásler M; Gundy S
Magy Onkol; 2003; 47(2):155-9. PubMed ID: 12975662
[TBL] [Abstract][Full Text] [Related]
5. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
6. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
7. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer.
Andratschke M; Chaubal S; Pauli C; Mack B; Hagedorn H; Wollenberg B
Anticancer Res; 2005; 25(4):2821-6. PubMed ID: 16080532
[TBL] [Abstract][Full Text] [Related]
9. [Problems occurring in the application of cytogenetic biomarkers for alcoholics with and without malignant diseases].
Gundy S; Székely G; Farkas G; Pulay A; Remenár E
Magy Onkol; 2008 Jun; 52(2):153-61. PubMed ID: 18640891
[TBL] [Abstract][Full Text] [Related]
10. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
11. [Steroid hormone receptors in squamous cell carcinoma of the head and neck].
Budai B; Remenár E; Orosz Z; Számel I; Kralovánszky J; Kásler M
Orv Hetil; 1997 Mar; 138(12):723-7. PubMed ID: 9157342
[TBL] [Abstract][Full Text] [Related]
12. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
Gottschlich S; Görögh T; Lippert BM; Niemann AM; Folz BJ; Werner JA
Anticancer Res; 1997; 17(4B):2921-2. PubMed ID: 9329564
[TBL] [Abstract][Full Text] [Related]
13. Associations between XPC expression, genotype, and the risk of head and neck cancer.
Yang M; Kang MJ; Choi Y; Kim CS; Lee SM; Park CW; Lee HS; Tae K
Environ Mol Mutagen; 2005 May; 45(4):374-9. PubMed ID: 15657918
[TBL] [Abstract][Full Text] [Related]
14. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients.
Hathaway B; Landsittel DP; Gooding W; Whiteside TL; Grandis JR; Siegfried JM; Bigbee WL; Ferris RL
Laryngoscope; 2005 Mar; 115(3):522-7. PubMed ID: 15744170
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
[TBL] [Abstract][Full Text] [Related]
17. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.
Dahlstrom KR; Little JA; Zafereo ME; Lung M; Wei Q; Sturgis EM
Head Neck; 2008 Jan; 30(1):75-84. PubMed ID: 17694557
[TBL] [Abstract][Full Text] [Related]
20. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
